Home/Filings/4/0000885590-13-000101
4//SEC Filing

Valeant Pharmaceuticals International, Inc. 4

Accession 0000885590-13-000101

$BHCCIK 0000885590operating

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:10 PM ET

Size

4.9 KB

Accession

0000885590-13-000101

Insider Transaction Report

Form 4
Period: 2013-12-14
Pearson J. Michael
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock, no par value

    2013-12-14$81.41/sh+184,247$14,999,5484,025,498 total
Footnotes (1)
  • [F1]This number represents the amount of shares purchased through a private transaction.

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000885590

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:10 PM ET
Size
4.9 KB